+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Opioid Drugs Market 2019-2028

  • ID: 5138682
  • Report
  • August 2020
  • Region: North America
  • 114 pages
  • Triton Market Research

FEATURED COMPANIES

  • Acura Pharmaceuticals
  • Daiichi Sankyo
  • Hikma Pharmaceuticals plc
  • Indivior Inc
  • Johnson Johnson
  • Lannett Co Inc
MARKET OUTLOOK

According to the publisher, the North American opioid drugs market is anticipated to rise with a CAGR of 2.36% in the estimated years 2019-2028. The United States and Canada together shape the market in this region.

Opioids or narcotics are the medications that doctors prescribe for treating severe or persistent pain. These are prescribed for use by people suffering from chronic lower back pain because of sedentary lifestyles, patients recovering surgery, and those experiencing cancer-associated pain. These are also used by those who have had bone injuries due to reduced bone density. There is a large market for opioid drugs market in the United States.

However, 2018’s statistics by the Drug Base Government show that, every day, 128 people in the country died due to an overdose of opioids. The abuse of and addiction to these substances, and the morbidity and mortality resulting due to these behaviors, is a serious national crisis. The US’ Department of Health and Human Services (HHS) has been dedicated in its efforts to tackle this crisis. With the help of the National Institutes of Health (NIH), it has been discovering new and better ways for the prevention of opioid misuse, treatment of disorders due to opioid abuse, and management of pain.

COMPETITIVE OUTLOOK

Some of the companies having their presence in this market are Allergan (Acquired By Abbvie), Janssen Pharmaceuticals Inc, Mylan NV, Johnson Johnson, Lupin Ltd, Hikma Pharmaceuticals Plc, Daiichi Sankyo, Teva Pharmaceutical Industries Ltd, and Acura Pharmaceuticals.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Acura Pharmaceuticals
  • Daiichi Sankyo
  • Hikma Pharmaceuticals plc
  • Indivior Inc
  • Johnson Johnson
  • Lannett Co Inc
1. North America Opioid Drugs Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. New Opportunities for Pharmaceutical Companies in the Us
2.2.2. Technological Advancements to Fight Against Opioid Drug Crisis
2.2.3. Different Sources of Procuring Opioids
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Growth in Medical Cases & Rising Prevalence of Cancer
2.6.2. Increase in the Use of Abuse-Deterrent Formulations to Restrict the Rise of Opioid Dependence
2.6.3. Demand for Palliative Therapy
2.7. Market Restraints
2.7.1. Government Rules and Regulations
2.7.2. Increased Number of Lawsuits Against the Manufacturers of Opiod Drugs
2.7.3. Usage of Opioids for Non-Medical Purposes
2.8. Market Opportunities
2.8.1. Rising Commercial Success and Market Share of Opioid Drugs
2.8.2. Growth of Investments in Research of Pharmaceutical Uses of Opioids
2.9. Market Challenges
2.9.1. Opioid Epidemic Spreading
2.9.2. Rising Death Rate Due to Opioid Overdose
2.10. Covid-19 Impact on the Opioid Drugs Market

3. North America Opioid Drugs Market Outlook - by Product
3.1. Buprenorphine
3.2. Fentanyl
3.3. Hydrocodone
3.4. Morphine
3.5. Oxycodone
3.6. Tramadol
3.7. Other Products

4. North America Opioid Drugss Market Outlook - by Application
4.1. Pain Relief
4.1.1. Cancer Pain
4.1.2. Postoperative Pain Management
4.1.3. Lower Back Pain
4.1.4. Orthopedic
4.1.5. Neuropathic
4.1.6. Fibromyalgia
4.2. Anesthesia
4.3. Cough Suppression
4.4. Diarrhea Suppression
4.5. De-Addiction

5. North America Opioid Drugs Market – Regional Outlook
5.1. United States
5.2. Canada

6. Competitive Landscape
6.1. Acura Pharmaceuticals
6.2. Biodelivery Sciences International Inc
6.3. Cipher Pharmaceuticals Inc
6.4. Allergan (Acquired by Abbvie)
6.5. Collegium Pharmaceutical Inc
6.6. Daiichi Sankyo
6.7. Hikma Pharmaceuticals plc
6.8. Indivior Inc
6.9. Janssen Pharmaceuticals Inc
6.10. Johnson Johnson
6.11. Lannett Co Inc
6.12. Lupin Ltd
6.13. Mylan Nv
6.14. Pfizer Inc
6.15. Purdue Pharma Lp
6.16. Sanofi-Aventis Sa
6.17. Sun Pharmaceutical Industries Ltd
6.18. Teva Pharmaceutical Industries Ltd

7. Methodology & Scope
7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

List of Tables:
Table 1: North America Opioid Drugs Market, by Country, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: North America Opioid Drugs Market, by Product, 2019-2028 (In $ Million)
Table 4: North America Opioid Drugs Market, by Application, 2019-2028 (In $ Million)
Table 5: North America Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Table 6: North America Opioid Drugs Market, by Country, 2019-2028 (In $ Million)

List of Figures:
Figure 1: Porter's Five Force Analysis
Figure 2: Market Attractiveness Index
Figure 3: North America Opioid Drugs Market, by Buprenorphine, 2019-2028 (In $ Million)
Figure 4: North America Opioid Drugs Market, by Fentanyl, 2019-2028 (In $ Million)
Figure 5: North America Opioid Drugs Market, by Hydrocodone, 2019-2028 (In $ Million)
Figure 6: North America Opioid Drugs Market, by Morphine, 2019-2028 (In $ Million)
Figure 7: North America Opioid Drugs Market, by Oxycodone, 2019-2028 (In $ Million)
Figure 8: North America Opioid Drugs Market, by Tramadol, 2019-2028 (In $ Million)
Figure 9: North America Opioid Drugs Market, by Other Products, 2019-2028 (In $ Million)
Figure 10: North America Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Figure 11: North America Opioid Drugs Market, by Cancer Pain, 2019-2028 (In $ Million)
Figure 12: North America Opioid Drugs Market, by Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 13: North America Opioid Drugs Market, by Lower Back Pain, 2019-2028 (In $ Million)
Figure 14: North America Opioid Drugs Market, by Orthopedic, 2019-2028 (In $ Million)
Figure 15: North America Opioid Drugs Market, by Neuropathic, 2019-2028 (In $ Million)
Figure 16: North America Opioid Drugs Market, by Fibromyalgia, 2019-2028 (In $ Million)
Figure 17: North America Opioid Drugs Market, by Anesthesia, 2019-2028 (In $ Million)
Figure 18: North America Opioid Drugs Market, by Cough Suppression, 2019-2028 (In $ Million)
Figure 19: North America Opioid Drugs Market, by Diarrhea Suppression, 2019-2028 (In $ Million)
Figure 20: North America Opioid Drugs Market, by De-Addiction, 2019-2028 (In $ Million)
Figure 21: North America Opioid Drugs Market; Regional Outlook 2019 & 2028 (In %)
Figure 22: United States Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 23: Canada Opioid Drugs Market, 2019-2028 (In $ Million)
Note: Product cover images may vary from those shown
  • Acura Pharmaceuticals
  • Biodelivery Sciences International Inc
  • Cipher Pharmaceuticals Inc
  • Allergan (Acquired by Abbvie)
  • Collegium Pharmaceutical Inc
  • Daiichi Sankyo
  • Hikma Pharmaceuticals plc
  • Indivior Inc
  • Janssen Pharmaceuticals Inc
  • Johnson Johnson
  • Lannett Co Inc
  • Lupin Ltd
  • Mylan Nv
  • Pfizer Inc
  • Purdue Pharma Lp
  • Sanofi-Aventis Sa
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll